Aspirin: all 652 studies that test it
Page 4 of 7. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.
- Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese CohortStatus unknownNCT04631627Phase 4
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCompletedNCT04588727Phase 1
- Transplacental Aspirin Therapy for Early Onset Fetal Growth RestrictionWithdrawnNCT04557475Phase 3
- Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerCompletedNCT04534218Phase 2
- Hemostasis in COVID-19: an Adaptive Clinical TrialStatus unknownNCT04466670Phase 2
- Genetic and Dietary Predictors of Anti-platelet ResponseTerminatedNCT04456608Phase 4
- ASPIrin in Reducing Events in Dialysis ( ASPIRED )Active, not recruitingNCT04381143Phase 4
- The Standardized Management of Hypertension in Rural ShaanxiCompletedNCT04371874Not applicable
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
- Protective Effect of Aspirin on COVID-19 PatientsStatus unknownNCT04365309Phase 2/3
- The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 HospitalizationsWithdrawnNCT04363840Phase 2
- Coronavirus Response - Active Support for Hospitalised Covid-19 PatientsWithdrawnNCT04343001Phase 3
- Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCIStatus unknownNCT04338919Not applicable
- Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.TerminatedNCT04333407Not applicable
- An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.CompletedNCT04330872Phase 4
- Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable AspirinCompletedNCT04328883Phase 1
- Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) TrialCompletedNCT04324463Phase 3
- Personalizing Aspirin Therapy in Peripheral Arterial Disease PatientsStatus unknownNCT04269863Not applicable
- Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation RecipientsStatus unknownNCT04260828Phase 4
- Prophylactic Anticoagulation for Catheter-related ThrombosisStatus unknownNCT04256525Phase 4
- A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT04188119Phase 2
- Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC PatientsCompletedNCT04184921Phase 2
- Aspirin (ASA) Therapy and Preeclampsia PreventionWithdrawnNCT04158830Phase 4
- Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityCompletedNCT04153760Early Phase 1
- One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart DiseaseStatus unknownNCT04148820Phase 4
- Aspirin Effects on Emotional ReactionsCompletedNCT04146532Early Phase 1
- Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTSTerminatedNCT04128956Phase 2
- Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior CirculationStatus unknownNCT04121611Not applicable
- Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)Status unknownNCT04088513Phase 4
- Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events IICompletedNCT04078737Phase 3
- VTE Prevention Following Total Hip and Knee ArthroplastyCompletedNCT04075240Phase 3
- Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for MelanomaCompletedNCT04066725Phase 2
- Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for MelanomaCompletedNCT04062032Phase 2
- Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin PregnanciesStatus unknownNCT04051567Phase 4
- Asprin Dosing Estimator in Healthy AdultsCompletedNCT04040465Early Phase 1
- COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
- Risk Stratification Procedure for Thromboembolism ProphylaxisCompletedNCT04031859Phase 2
- Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin ComplexCompletedNCT04008979Phase 1
- Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki DiseaseCompletedNCT04003844Phase 4
- Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMCompletedNCT03927313Phase 2
- Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal CarcinomaStatus unknownNCT03900871Early Phase 1
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryActive, not recruitingNCT03899987Phase 2
- Ticagrelol Versus Aspirin in Ischemic StrokeCompletedNCT03884530Phase 3
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACSCompletedNCT03881943Phase 4
- Aggravated Airway Inflammation: Research on Genomics and Optimal Medical Care (AirGOs-medical)CompletedNCT03825757Not applicable
- Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial FibrillationStatus unknownNCT03821883Not applicable
- Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive TroponinTerminatedNCT03820466Phase 3
- Aspirin to Target Arterial Events in Chronic Kidney DiseaseTerminatedNCT03796156Phase 3
- A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT03794596Phase 2
- Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian TubeActive, not recruitingNCT03771651Early Phase 1
- Postoperative Aspirin and Ankle Fracture HealingCompletedNCT03765619Early Phase 1
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTENDTerminatedNCT03729401Phase 4
- Aspirin for Prevention of PreeclampsiaStatus unknownNCT03726177Not applicable
- Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant WomenStatus unknownNCT03725891Not applicable
- A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy SubjectsCompletedNCT03698513Phase 1
- Trial of Early Screening Test for Pre-eclampsia and Growth RestrictionCompletedNCT03674606Phase 4
- Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT).Status unknownNCT03661463Phase 2
- Antiplatelet vs R-tPA for Acute Mild Ischemic StrokeCompletedNCT03661411Phase 4
- Screening and Multiple Intervention on Lung EpidemicsActive, not recruitingNCT03654105Phase 2
- Coronary Artery Disease After Heart TransplantationStatus unknownNCT03583229Not applicable
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in DiabetesCompletedNCT03574909Phase 3
- Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma PatientsCompletedNCT03558854Phase 4
- Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLCCompletedNCT03543683Phase 2
- Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)CompletedNCT03487406Phase 2
- ASA in Prevention of Ovarian Cancer (STICs and STONEs)Active, not recruitingNCT03480776Phase 2
- ASPIRIN Trial BelgiumActive, not recruitingNCT03464305Phase 3
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical TherapyCompletedNCT03463317Phase 4
- Influence of Aspirin on Human Gut Microbiota Composition and MetabolomeStatus unknownNCT03450317Not applicable
- COMT on Aspirin Platelets Effects (CAPE)Status unknownNCT03433586Phase 4
- Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking AspirinCompletedNCT03424408Not applicable
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CADActive, not recruitingNCT03417388Phase 4
- Aspirin in the Prevention of Collapse in Osteonecrosis of the HipStatus unknownNCT03405974Phase 3
- IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOCCompletedNCT03378297Early Phase 1
- Sleep and Inflammatory Resolution PathwayActive, not recruitingNCT03377543Early Phase 1
- Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis ComplexStatus unknownNCT03356769Phase 2
- Acetylsalicylic Acid and Type 2 Diabetes MellitusCompletedNCT03341117Phase 3
- Aspirin in Colorectal Cancer Liver MetastasesCompletedNCT03326791Phase 2/3
- Antiplatelet Therapy for Silent Brain InfarctionStatus unknownNCT03318744Not applicable
- Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected PatientsCompletedNCT03316534Phase 2
- Mechanism of Drug-drug Interaction Between Salvianolate Injection and AspirinStatus unknownNCT03306550Not applicable
- Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03290820Phase 2
- The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct ObstructionTerminatedNCT03279809Not applicable
- Role of Anti-platelet in Treatment of Acute Ischemic StrokeStatus unknownNCT03266731Not applicable
- Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-ProtocolStatus unknownNCT03263299Phase 4
- the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet TherapyStatus unknownNCT03230851Phase 4
- A Study to Assess Disintegration of the New Aspirin Disintegrating TabletsCompletedNCT03225352Phase 1
- A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)TerminatedNCT03224923Phase 4
- Antiplatlet Effects of Standardized Tomato Extract in Hypertensive SubjectsCompletedNCT03206944Phase 4
- Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent ImplantationCompletedNCT03198741Phase 4
- A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy SubjectsCompletedNCT03197779Phase 1
- Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal CancerTerminatedNCT03170115Phase 2
- Topical Analgesic Versus Saline Mouth Rinses in Post Extraction HealingCompletedNCT03130153Early Phase 1
- Chronic Subdural Hematoma and AspirinCompletedNCT03120182Not applicable
- P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldTerminatedNCT03119012Phase 4
- Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPTStatus unknownNCT03112707Phase 4
- Study of Aspirin in Patients With Vestibular SchwannomaActive, not recruitingNCT03079999Phase 2
- Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial AneurysmsStatus unknownNCT03063541Phase 3
- Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin TabletsCompletedNCT03056703Phase 1
- Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting StentsCompletedNCT03056118Phase 4
- Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass GraftingStatus unknownNCT03049085Phase 4